BETonMACE baseline medications were listed in the ACC poster last week. For a complete list, see this post or the ACC poster. For diabetes baseline medications in the BETonMACE population, the list from the poster is copied below. The number is the number of patients out of 2425, followed by the percent in parentheses.

Insulin 878 (36.2%)

Metformin 1,933 (79.7%)

Sulfonylureas 685 (28.2%) 

GLP-1 Agonists 10 (0.4%) 

DPP-4 Inhibitors 277 (11.4%) 

SGLT2 Inhibitors 266 (11.0%)